Abstract:Normal cardiac function relies on highly coordinated intracellular events, such as calcium cycling and contraction, with adequate mitochondrial energy metabolism. However, mitochondrial respiration unavoidably produces reactive oxygen species (ROS) as electrons leak from the electron transport chain (ETC). Complex I of the ETC is believed to be the major site for ROS generation in the mitochondria. However, suppression of Complex I activity by chemical inhibitors leads to oxidative cell damage. In this study, we used a genetic model of Complex I deficiency, in which a key component of Complex I, Ndufs4, was deleted in the heart, to determine the causal role of Complex I in ischemia-reperfusion-induced oxidative stress in adult cardiac myocytes. Germline deletion of Ndufs4 in the heart (Ndufs4H-/-) leads to a ~75% decline of Complex I activity in cardiac mitochondria without obvious disease phenotype in the mice. As predicted, the mitochondrial respiration-coupled superoxide production events, superoxide flashes, were significantly decreased at baseline in the Ndufs4H-/- myocytes. Respiration substrate (pyruvate, 20 mM) failed to stimulate mitochondrial superoxide flash production in Ndufs4H-/- myocytes. This is accompanied by the slightly decreased steady state intracellular and mitochondrial ROS levels determined by the targeted H2O2 indicator, Hyper. The intracellular redox homeostasis is also tilted toward more reduced state, since the NADH/NAD ratio increased 67%. Surprisingly, ischemia reperfusion mimetic treatment of the myocytes caused dramatic increase in mitochondrial ROS production in Ndufs4H-/- groups, which contributed to the elevated overall cellular oxidative status. Overexpression of catalase in the mitochondria prevented these effects. Mechanistically, increased reducing equivalent (NADH) contributed to the dramatic ROS production during ischemia and reperfusion in Ndufs4H-/- myocytes. In summary, mitochondrial Complex I plays a critical role in controlling mitochondrial and cytosolic ROS homeostasis under normal conditions, and compromised Complex I function leads to accumulation of electron donors that paradoxically promote ROS production during ischemia reperfusion.

Importance of Mitochondria in Cardiac Pathologies: Focus on Uncoupling Proteins and Monoamine Oxidases

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitochondrial reactive oxygen species production and elimination

The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury

Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury

Abstract 224: Mitochondrial Complex I Deficiency Promotes Oxidative Stress During Ischemia Reperfusion of Cardiac Myocytes

Reactive Oxygen Species Regulate Myocardial Mitochondria Through Post-Translational Modification

Superoxide Flashes: Illuminating New Insights into Cardiac Ischemia/reperfusion Injury.

The role of mitochondria in cardiac development and protection

Mitochondrial calcium regulation of cardiac metabolism in health and disease

ER–Mitochondria Microdomains in Cardiac Ischemia–Reperfusion Injury: A Fresh Perspective

Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome.

The role of reactive oxygen species in myocardial redox signaling and regulation

Redox mechanisms of cardiomyocyte mitochondrial protection

Mitochondrial electron transport chain, ROS generation and uncoupling (Review)

Super-suppression of Mitochondrial Reactive Oxygen Species Signaling Impairs Compensatory Autophagy in Primary Mitophagic Cardiomyopathy.

Yin and Yang of NADPH Oxidases in Myocardial Ischemia-Reperfusion

Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium

Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling

Mitochondrial Proton Leak Plays a Critical Role in Pathogenesis of Cardiovascular Diseases.

The role of mitochondrial membrane potential in ischemic heart failure